I now have comprehensive, current information including the 2026 indigenous Td vaccine launch. Here is the complete picture:
Tetanus Vaccine Protocol - India (Current, Updated 2026)
Key Policy Change: TT → Td
The most significant recent update in India's immunization schedule is the replacement of the standalone Tetanus Toxoid (TT) vaccine with the combination Tetanus-Diphtheria (Td) vaccine across the Universal Immunization Programme (UIP). This applies to school-age children (10 and 16 years) and pregnant women. The rationale is dual protection against both tetanus and diphtheria.
Current National Immunization Schedule (NIS) - Tetanus/Td Component
Infants and Children (UIP - Free at Government Centres)
| Age | Vaccine | Notes |
|---|
| 6 weeks | Pentavalent-1 (DTP + HepB + Hib) | Primary series dose 1 |
| 10 weeks | Pentavalent-2 | Primary series dose 2 |
| 14 weeks | Pentavalent-3 | Primary series dose 3 |
| 16-24 months | DPT Booster-1 | 1st booster |
| 5-6 years | DPT Booster-2 | 2nd booster |
| 10 years | Td | Replaces old TT dose |
| 16 years | Td | Replaces old TT dose |
- The Pentavalent vaccine (DTwP + HepB + Hib) replaced standalone DPT and Hepatitis B injections and is the backbone of the primary series.
Pregnant Women
| Dose | Timing | Notes |
|---|
| Td-1 | At time of first ANC visit / as soon as pregnancy confirmed | For unvaccinated women |
| Td-2 | Minimum 4 weeks after Td-1 | |
| Td Booster | Single dose | If previously received 2 doses of Td/TT within the past 3 years |
Women who received a complete Td series in a previous pregnancy within 3 years need only 1 booster dose. If the previous vaccination was more than 3 years ago, the full Td-1 + Td-2 schedule is repeated.
2026 Update: Indigenous Td Vaccine Launch
A major 2026 development: on
21 February 2026, India launched an
indigenously manufactured Tetanus & Adult Diphtheria (Td) vaccine, produced at the
Central Research Institute (CRI), Kasauli. Approximately
55 lakh (5.5 million) doses were to be supplied to UIP by April 2026. This reduces import dependence and strengthens domestic vaccine supply security. -
PIB Press Release, March 2026
Why Td Instead of TT?
- Diphtheria resurgence concern: Immunity from childhood DPT wanes in adolescence and adulthood. The TT-only booster gave no diphtheria protection; Td corrects this.
- WHO recommendation: WHO recommends Td in place of TT for adolescent/adult boosters to maintain population-level diphtheria immunity.
- Pregnant women: Td during pregnancy protects both mother (from diphtheria) and neonate (from tetanus via transplacental antibodies).
Wound Management Protocol (Post-Injury Tetanus Prophylaxis)
| Vaccination History | Clean Minor Wound | Tetanus-Prone Wound |
|---|
| Unknown / < 3 doses | Td vaccine + TIG (Tetanus Immune Globulin) | Td + TIG |
| 3 or more doses, last dose < 5 years ago | No vaccine needed | No vaccine needed |
| 3 or more doses, last dose 5-10 years ago | No vaccine needed | Td vaccine |
| 3 or more doses, last dose > 10 years ago | Td vaccine | Td + TIG |
TIG dose: 250-500 IU IM at a different site from the vaccine.
Maternal and Neonatal Tetanus (MNT) Elimination Status
India was validated for elimination of Maternal and Neonatal Tetanus (defined as <1 case per 1,000 live births per district). Key strategies included:
- Systematic TT/Td vaccination of pregnant women through ANC
- Janani Suraksha Yojana (JSY) promoting institutional deliveries
- Promotion of the "5 Cleans" for cord care
- Distribution of disposable delivery kits to skilled birth attendants
- Full immunization coverage rose from 62% in 2015 to 98.4% in January 2026
(Park's Textbook of Preventive and Social Medicine)
Summary of the TT → Td Transition (at a glance)
| Feature | Old (TT) | New (Td) |
|---|
| Antigen | Tetanus toxoid only | Tetanus + adult-dose Diphtheria |
| Used in children 10 & 16 yr | Yes (TT) | Replaced by Td |
| Used in pregnancy | TT (2 doses or booster) | Td (same schedule) |
| Manufactured indigenously | Imported | CRI Kasauli (from Feb 2026) |
The IAP (Indian Academy of Pediatrics) 2025 schedule aligns with the UIP Td schedule and recommends Tdap (Tetanus-diphtheria-acellular Pertussis) as an alternative in the private sector for additional pertussis coverage, especially for adolescents and in pregnancy.